Physician profile
Ethan D Ly
NPI 1649290701
$6,861.91
in general payments reported to CMS, 2019-2025
15 companies · $566 in 2025
The $566 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,490 · 2020: $357 · 2021: $677 · 2022: $873 · 2023: $1,224 · 2024: $676 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,465.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,625.19 | 2019-2025 | Total30, Precision7, Argos |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $983.82 | 2019-2021 | |
| Coopervision INC. | $913.68 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Cvi Contact Lens |
| Bausch & Lomb Americas INC. | $662.15 | 2022-2024 | Infuse, Infuse Multifocal, Miebo |
| Tg Therapeutics, INC. | $242.31 | 2023-2025 | |
| Carl Zeiss Meditec, INC. | $239.74 | 2019 | |
| Abbvie INC. | $237.29 | 2022-2023 | |
| Johnson & Johnson Vision Care, INC. | $233.69 | 2019-2024 | Acuvue |
| Biotissue Holdings INC. | $152.59 | 2024 | |
| Dompe US, INC. | $125.00 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $121.30 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $119.53 | 2023 | Tyrvaya |
| Allergan, INC. | $106.81 | 2022 | |
| Glaukos Corporation | $77.16 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.65 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.